Literature DB >> 8456534

Short-term culture of exfoliated cells from the urine of patients with bladder tumors.

F Herz1, D Deitch, S A Adler, D Brijlall.   

Abstract

This report concerns the short-term culture of urothelial cells from the urine sediment of over 100 patients with bladder tumors. Primary cell outgrowth was obtained in approximately 60% of the cultures initiated. Culture outcome was not related to tumor grade, patient age, or volume of the urine sample. Around 85% of the proliferating cultures were successfully transferred into multi-compartment chamber/slides. These results suggest that the culture system may be a useful tool for the study of urothelial cells using patient material obtained by non-invasive means.

Entities:  

Mesh:

Year:  1993        PMID: 8456534     DOI: 10.1007/bf00295187

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  14 in total

Review 1.  Biological markers of prognosis in invasive bladder cancer.

Authors:  Y Fradet
Journal:  Semin Oncol       Date:  1990-10       Impact factor: 4.929

Review 2.  Recent advances in the polymerase chain reaction.

Authors:  H A Erlich; D Gelfand; J J Sninsky
Journal:  Science       Date:  1991-06-21       Impact factor: 47.728

3.  Short-term culture of epithelial cells from urine of adults.

Authors:  F Herz; A Schermer; L G Koss
Journal:  Proc Soc Exp Biol Med       Date:  1979-06

4.  Normal human urothelial cells in culture. Subculture procedure, flow cytometric and chromosomal analyses.

Authors:  F Herz; P Gazivoda; P R Papenhausen; J Katsuyama; L G Koss
Journal:  Lab Invest       Date:  1985-11       Impact factor: 5.662

Review 5.  Flow cytometric measurements of DNA and other cell components in human tumors: a critical appraisal.

Authors:  L G Koss; B Czerniak; F Herz; R P Wersto
Journal:  Hum Pathol       Date:  1989-06       Impact factor: 3.466

6.  Comparison of 15 monoclonal antibodies against tumor-associated antigens of transitional cell carcinoma of the human bladder.

Authors:  E Huland; H Huland; T Meier; O Baricordi; Y Fradet; H B Grossman; G M Hodges; E M Messing; B J Schmitz-Draeger
Journal:  J Urol       Date:  1991-12       Impact factor: 7.450

7.  Identification of p53 gene mutations in bladder cancers and urine samples.

Authors:  D Sidransky; A Von Eschenbach; Y C Tsai; P Jones; I Summerhayes; F Marshall; M Paul; P Green; S R Hamilton; P Frost
Journal:  Science       Date:  1991-05-03       Impact factor: 47.728

8.  Preferential and novel activation of H-ras in human bladder carcinomas.

Authors:  K V Visvanathan; R D Pocock; I C Summerhayes
Journal:  Oncogene Res       Date:  1988

9.  Mutation affecting the 12th amino acid of the c-Ha-ras oncogene product occurs infrequently in human cancer.

Authors:  A P Feinberg; B Vogelstein; M J Droller; S B Baylin; B D Nelkin
Journal:  Science       Date:  1983-06-10       Impact factor: 47.728

10.  Quantitation of oncogene products by computer-assisted image analysis and flow cytometry.

Authors:  B Czerniak; F Herz; R P Wersto; P Alster; E Puszkin; E Schwarz; L G Koss
Journal:  J Histochem Cytochem       Date:  1990-04       Impact factor: 2.479

View more
  3 in total

1.  Immunocytochemical detection of p53 in cultures of exfoliated cells from urine of patients with urothelial cancers.

Authors:  H Okuno; Y Kakehi; O Ogawa; H Yamada; E Ozdemir; Y Okada; O Yoshida
Journal:  Jpn J Cancer Res       Date:  1996-07

2.  A new and reliable culture system for superficial low-grade urothelial carcinoma of the bladder.

Authors:  Hans-Helge Seifert; Andrea Meyer; Marcus V Cronauer; Jiri Hatina; Mirko Müller; Harald Rieder; Michele J Hoffmann; Rolf Ackermann; Wolfgang A Schulz
Journal:  World J Urol       Date:  2007-04-18       Impact factor: 3.661

3.  Speciation of arsenic in exfoliated urinary bladder epithelial cells from individuals exposed to arsenic in drinking water.

Authors:  Araceli Hernández-Zavala; Olga L Valenzuela; Tomás Matousek; Zuzana Drobná; Jirí Dĕdina; Gonzalo G García-Vargas; David J Thomas; Luz M Del Razo; Miroslav Stýblo
Journal:  Environ Health Perspect       Date:  2008-07-18       Impact factor: 9.031

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.